Skip to content

Automatic Segmentation of Polycystic Liver

Automatic Segmentation by a Convolutional Neural Network (Artificial Intelligence - Deep Learning) of Polycystic Livers, as a Model of Multi-lesional Dysmorphic Livers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03960710
Acronym
ASEPOL
Enrollment
120
Registered
2019-05-23
Start date
2019-04-01
Completion date
2019-09-30
Last updated
2019-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Injury, Polycystic Hepatorenal Disease, Polycystic Liver Disease

Brief summary

Assessing the volume of the liver before surgery, predicting the volume of liver remaining after surgery, detecting primary or secondary lesions in the liver parenchyma are common applications that require optimal detection of liver contours, and therefore liver segmentation. Several manual and laborious, semi-automatic and even automatic techniques exist. However, severe pathology deforming the contours of the liver (multi-metastatic livers...), the hepatic environment of similar density to the liver or lesions, the CT examination technique are all variables that make it difficult to detect the contours. Current techniques, even automatic ones, are limited in this type of case (not rare) and most often require readjustments that make automatisation lose its value. All these criteria of segmentation difficulties are gathered in the livers of hepatorenal polycystosis, which therefore constitute an adapted study model for the development of an automatic segmentation tool. To obtain an automatic segmentation of any lesional liver, by exceeding the criteria of difficulty considered, investigators have developed a convolutional neural network (artificial intelligence - deep learning) useful for clinical practice.

Interventions

OTHERAnonymized CT examinations

The anonymized CT examinations will be reviewed in Lyon, in the imaging department of Edouard Herriot Hospital, by an expert radiologist and an intern from the Lyon hospitals.

OTHERTraining (1)

An initial training phase of the artificial intelligence network will be carried out : \- Segmentation of the livers of a first part of the CT examination, by an intern of the Lyon hospitals

OTHERTraining (2)

An initial training phase of the artificial intelligence network will be carried out : \- Use of computer data to drive the artificial intelligence network.

OTHERValidation (1)

A validation phase of the artificial intelligence tool will be carried out with segmentation of the livers of the second part of the CT examinations : \- Carried out by an intern at the Lyon hospitals

OTHERValidation (2)

A validation phase of the artificial intelligence tool will be carried out with segmentation of the livers of the second part of the CT examinations : \- Carried out by the neural network

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥ 18 years old * Patients with hepato-renal polycystosis, with or without surgery * Patients with at least one abdominal-pelvic CT scan without injection or with injection between January 1, 2016 and August 2018 * Patients with good quality and available images

Exclusion criteria

* Patients with no CT scan images available * Patients with bad quality of CT scan images

Design outcomes

Primary

MeasureTime frameDescription
Test of automatic segmentation by the convolutional neural network on these group and collection of data setAt 4 months after randomizationDevelopment of an automatic segmentation tool for highly dysmorphic polycystic livers as a prerequisite for segmentation of any type of multi-lesional livers that are difficult to segment, in order to facilitate lesion detection and volume measurement in clinical practice. Randomisation of the patient into two data groups, one for training the other for Validating the convolutional neural network (artificial intelligence) * Manual segmentation of polycystic livers of the 1st training group and deep learning of convolutional neural network * Manual segmentation of polycystic livers of 2nd validation group * Test of automatic segmentation by the convolutional neural network on these group and collection of data set

Countries

France

Contacts

Primary ContactBénédicte CAYOT
benedicte.cayot@chu-lyon.fr472110400
Backup ContactPierre-Jean VALETTE, MD, Prof.
pierre-jean.valette@chu-lyon.fr472117544

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026